Secretory immunoglobulin A: A protective factor in the genital mucosa

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 4, 2006, Pages 232-234

  Giraldo, Paulo Cesar ^a   Gonçalves, Ana Katherine ^b   Eleutério Jr , José ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Candida albicans; Genital infections; HPV; Secretory IgA; Vaginal immunity

Indexed keywords

SECRETORY IMMUNOGLOBULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; CANDIDIASIS; CELLULAR IMMUNITY; DEFENSE MECHANISM; FEMALE GENITAL SYSTEM; FUNGAL STRAIN; GENE FUNCTION; HUMAN; IMMUNE DEFICIENCY; LYMPHOID TISSUE; PROTECTION; TREATMENT FAILURE; VAGINA FLORA; VAGINA MUCOSA; VIRUS STRAIN;

FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; MUCOUS MEMBRANE; SEXUALLY TRANSMITTED DISEASES; VAGINA;

EID: 33947425903     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702006000400002     Document Type: Article

References (28)

1. Gorczynski R., Stanley J. Imunologia clínica. Reichmann, Rio de Janeiro; 2001.
2. a. ed., WB Saunders, California; 2003.
3. a. ed., São Paulo: Manole; 2003.
4. Witkin S.S., Hirsch J., Ledger W.J. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am Obstet Gynecol 1986;155:790-5.
5. Witkin S.S. Immunologic factors influencing susceptibility to recurrent candidal vulvovaginites. Clin Obstet Gynecol 1991;34:662-8.
6. Rhoads J.C., Wrign C., Reolfield R.R., Burke D.S. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3107-7.
7. Benton C., Shaidulah H., Hunter J.A. Human Papillomavirus in the immunosuppressed. Papillomavirus Rep 1992;3:23-6.
8. Chirgwin K.D., Feldman J., Augenbraun M., et al. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis 1995;172(1):235-8.
9. Sedlacek T.V. Advances in the diagnosis and treatment of Human Papillomavirus infections. Clin Obstet Gynecol 1999; 42(2):206-20.
10. Scott M., Nakagawa M., Moscicki A.B. Cell-mediated immume response to Human Papillomavirus infection. Clin Diag Lab Immunol 2001;8(2):209-20.
11. Wan A.K., Seow W.K., Purdie D.M., et al. Immunoglobulins in saliva of preterm and full-term infants. Oral Microbiol. Immunol 2003;18(2):72-8.
12. Brandtzaeg P., Baekkevold E.S., Farstad I.M., et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999;20(3):141-51.
13. Jankovic J., Jelic C., Filipovic-Jeskovic I., Ristovic Z. Salivary immunoglobulins in cancer patients with chemotherapy related oral mucosa damage. Eur J Cancer Oral Oncol 1995;31B(3):160-5.
14. Tappuni A.R., Challacombe S.J. A comparison of salivary immunoglobulin A (IgA) and IgA subclass concentrations in predentate and dentate children and adults. Oral Microbiol. Immunol 1994;9(3):142-5.
15. Ventura M.T. Evaluation of IgA1-IgA2 levels in serum and saliva of young and elderly people. Allergol. Immunopathol 1991; 19(5):183-5.
16. Russell M.W., Mestecky J. Humoral immune responses to microbial infections in the genital tract. Microbes Infect 2002;4(6):667-77.
17. Russell M.W. IgA as an anti-inflammatory regulator of immunity. Oral Dis 1995:55-67.
18. Egmond M.V., Damen C.A., Spriel A.B.V., et al.IgA and IgA Fc receptor. Trends Immunol 2001;22(4):205-11.
19. Kaul R., Trabattoni D., Bwayo J.J., et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;4(1):23-9.
20. Kaul R., Plummer F.A., Clerici M., et al. Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection. AIDS 2001;15(3):431-2.
21. Devito C., Hinkula J., Kaul R., et al. Mucosal and plasma Iga from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 2000A;8(13):1917-20.
22. Devito C., Broliden K., Kaul R., et al. Mucosal and plasma iga from hiv-1-exposed uninfected individuals inhibit hiv-1 transcytosis across human epithelial cells. J Immunol 2000B;1(9):5170-6
23. Grassegger A., Rollinger-Holzinger I., Zelger B.W.H., et al. Spontaneous or interferon-g-induced t-cell infiltration, hla-dr and icam-1 expression in genitoanal warts are associated with th1 or mixed th1/th2 cytokine mma expression profiles. Arch Dermat Res 1997;289:243-50.
24. Clerici M., Merola M.,Ferrario E., et al. Cytokine production patterns in cervical. Intraepithelial. Neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997;89:245-50.
25. Tartour E., Gey A., Sastre-Garau X., et al. prognostic value of intratumoral vaginal interferon gamma messenger ma expression in invasive cervical carcinomas. J Natl Cancer Inst 1998;90:287-94.
26. Thapar M.A., Parr E.L., Parr M.B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunol 1990;70:121-25.
27. Balmelli C., Roden R., Potts A., et al. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J. Virol 1998;72(10):8220-29.
28. Gonçalves A.K.S., Giraldo P., Barros-Mazon S., et al. Secretory immunoglobulin A. Eur J Obstet Gynecol Reprod Biol 2006;Feb124(2):227-31.